Biotech is going to the dogs – and big profits await

Pet lovers around the world are spurring animal health companies to invest in developing complex new treatments previously reserved for humans.
Pet lovers around the world are spurring animal health companies to invest in developing complex new treatments previously reserved for humans.
No Comments